Search
for
Sort by
Research 271–300 of 1000+
- Complications of liver transplantation: A perioperative perspective
- The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine
- Dermatologic manifestations of endocrine disorders
- Cytostatics and immunosuppressive drugs
- Description of skin lesions
- Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications
- Anthracycline analogs The past, present, and future
- Cutaneous reactions to recombinant cytokine therapy
- Aging in hair follicle stem cells and niche microenvironment
- The Clinical Presentation of Systemic Lupus Erythematosus
- Bariatric Surgery and Its Effects on the Skin and Skin Diseases
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- Chemoprevention of doxorubicin-induced alopecia in mice by dietary administration of l-cystine and vitamin B6
- Drug eruptions in dermatology
- The Skin and Subcutaneous Tissues
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- ANTINOCICEPTIVE ACTIVITY OF ADIANTUM CAPILLUS IN EXPERIMENTAL ANIMALS
- A randomized study of eflornithine cream combined with intense pulsed light versus intense pulsed light treatment alone for hirsutism in women
- Index
- TOC
- CME examination for volume 43
- Androgenic disorders
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- The Basic Science of Hair Biology
- Endocrinology & Metabolism News, August 2005
- Androgens in SARS-CoV-2 Coronavirus Infections
- Scaffolds for epithelial and hair follicle regeneration
- A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment